Answer:
Sickle cell anemia is an inherited condition in which there aren't enough healthy red blood cells to carry oxygen through an individual's body. The red blood cells of a healthy individual are flexible and round, and they move through blood vessels with no problem, transporting oxygen successfully. However, a person with sickle cell anemia has rigid, sticky red blood shaped like sickles or crescent moons. These cells often get stuck in small blood vessels, which can slow or block blood flow and oxygen delivery to different parts of the body.
The sickle cell anemia trait is found on a recessive allele of the hemoglobin gene, while the regular red blood cell trait is found on the dominant allele. This means that a person must have two copies of the recessive allele (one from their mother and the other from their father) to be born with this condition. People who have one dominant and one recessive allele or both dominant alleles will have healthy red blood cells.
Answer:
Yes they can.
Explanation:
I defined the genotypes and possible outcomes in the image attached
Answer:
Explanation:
A woman with type A blood (whose father was type O) meaning her genotype is AO mates with
Man that has type O blood (OO genotype)
Both are heterozygous for MN blood group and both also heterozygous for the FUT1 gene controlling the synthesis of the H substance (Hh)- which determines the expression of the A and B antigen.
Cross
A O M N H h
O AO OO M MM MN H HH Hh
O AO OO N MN NN h Hh hh
Type A- 1/2 O-1/2 type M- 1/4 MN-1/2 N- 1/4, type H- 3/4 h-1/4
Type A with M antigen:
1/2*1/4*3/4 = 3/32
Type A with M and N antigens:
1/2*1/2*3/4 = 3/16
Type A with N antigen:
1/2*1/4*3/4 = 3/32
Type O with M antigen:
1/2*1/4*3/4= 3/32
Type O with M and N antigens:
1/2*1/2*3/4 = 3/16
Type O with N antigen:
1/2*1/4*3/4 = 3/32.
The 3/4 value comes from the expression of Hh-3/4 (this determines if the A and B Angie will be expressed).
Answer:
1. Isolation of donor DNA fragment or gene.
2. Selection of suitable vector.
3. Incorporation of donor DNA fragment into the vector.
4. Transformation of recombinant vector into a suitable host cell.
5. Isolation of recombinant host cell.
